Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota

University of Minnesota (UMN)

Status

Withdrawn

Conditions

Corona Virus Infection

SARS-CoV Infection

Covid19

SARS-CoV-2

Treatments

Diagnostic Test: Specimen Collection

Diagnostic Test: Surveys

Study type

Observational

Funder types

Other

Identifiers

NCT04473183

SURG-2020-28863

Details and patient eligibility

About

The purpose of this epidemiologic study is to estimate the prevalence and incidence of anti-SARS-CoV-2 antibodies in at-risk, exposed, affected populations. The study will also estimate the risk of SARS-CoV-2 exposure in target population.

Full description

This study is not for real-time diagnostic purposes, guidance for patient care, or the development of a diagnostic test. The research tests performed for this study will not be prioritized over clinical care samples, that research samples will be batched and tested after clinical care samples. This study is a population-based epidemiologic analysis of prevalence of various groups of persons.

Group (1) general healthy population. People 18 years of age and older that have not tested positive for SARS-CoV-2 and who have not sought medical help in the previous 4 months.

Group (2) Medical School Residents , 18 years of age and older that have not tested positive for SARS-CoV-2 Group (3) Individuals who are HIV positive. People 18 years of age and older that have not tested positive for SARS-CoV-2

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Participants in Group 1 (General Healthy Population) must have no known exposure to SARS-CoV-2 and have not sought medical help in the previous 4 months for SARS-CoV-2-related symptoms
Participants in Group 2 must be currently enrolled in a medical residency program
Participants in Group 3 must currently test positive for HIV infection

Exclusion criteria

Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the participant or the quality of the data (e.g., someone not able to answer the questionnaire because of a psychological condition or an anxiety disorder that is severe).
Contraindication for routine blood draws (e.g., severe anemia, hemophilia, etc)

Trial design

0 participants in 3 patient groups

General Healthy Population

Description:

Participants in this group are part of the general healthy population of adults 18 years-of-age and older, not known to be exposed to the virus as reported by potential participants and who have not sought medical help in the previous 4 months.

Treatment:

Diagnostic Test: Specimen Collection

Diagnostic Test: Surveys

Medical School Residents

Description:

Participants in this group are medical school residents.

Treatment:

Diagnostic Test: Specimen Collection

Diagnostic Test: Surveys

Individuals who are HIV positive

Description:

Participants in this group are HIV positive.